8 Coupons
-
Special Offer
-
30% off
.eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
.
"we were quite surprised to find there were no significant differences," says study author
.
.
.china is host to 70 percent of all car cell therapy trials registered in 2017 and the first four months of 2018 (150 out of 214).
.
.